½ÃÀ庸°í¼­
»óǰÄÚµå
1465620

¼¼°èÀÇ ÇǺΠ¾Ë·¹¸£±â °Ë»ç ½ÃÀå

Global Skin Allergy Testing Market

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: BCC Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 75 Pages | ¹è¼Û¾È³» : Áï½Ã¹è¼Û

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è ÇǺΠ¾Ë·¹¸£±â °Ë»ç ½ÃÀå ±Ô¸ð´Â 2023³â 5¾ï 6,000¸¸ ´Þ·¯¿¡¼­ ¿¹Ãø ±â°£ µ¿¾È 6.6%ÀÇ CAGR·Î 2028³â ¸»¿¡´Â 7¾ï 7,150¸¸ ´Þ·¯ ±Ô¸ð·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÇǺΠ¹ÝÀÀ Å×½ºÆ® ºÎ¹®Àº 2023³â 4¾ï 8,930¸¸ ´Þ·¯¿¡¼­ °°Àº ±â°£ µ¿¾È 6.8%ÀÇ CAGRÀ» ±â·ÏÇϸç 2028³â¿¡´Â 6¾ï 7,860¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ÆÐÄ¡ Å×½ºÆ® ºÎ¹®Àº 2023³â 4,010¸¸ ´Þ·¯¿¡¼­ ¿¬Æò±Õ 6.1%ÀÇ CAGR·Î 2028³â¿¡´Â 5,400¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼¼°è ÇǺΠ¾Ë·¹¸£±â °Ë»ç ½ÃÀåÀ» Á¶»çÇßÀ¸¸ç, ½ÃÀå °³¿ä, ±ÔÁ¦ ȯ°æ, ½ÃÀå ¿µÇâ¿äÀÎ ¹× ½ÃÀå ±âȸ ºÐ¼®, ½ÃÀå ±Ô¸ð ÃßÁ¤ ¹× ¿¹Ãø, °¢Á¾ ºÎ¹®º°¡¤Áö¿ªº° »ó¼¼ ºÐ¼®, °æÀï »óȲ, ÁÖ¿ä ±â¾÷ °³¿ä µîÀÇ Á¤º¸¸¦ Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀå Àü¸Á
  • Á¶»ç ¹üÀ§
  • ½ÃÀå ¿ä¾à

Á¦2Àå ½ÃÀå °³¿ä

  • °³¿ä
  • PESTEL ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • °ø±Þ¸Á ºÐ¼®

Á¦3Àå ½ÃÀå ¿ªÇÐ

  • ½ÃÀå ¿ªÇÐ
  • ¼ºÀå ÃËÁø¿äÀÎ
  • ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ±âȸ
  • °úÁ¦

Á¦4Àå ½Å±â¼ú°ú °³¹ß

  • ½Å±â¼ú
  • ÀÚµ¿ ÇǺΠ¹ÝÀÀ Å×½ºÆ® ±â±â
  • µðÁöÅÐÈ­
  • AI
  • ÀÓ»ó½ÃÇè ºÐ¼®
  • ƯÇ㠺м®

Á¦5Àå ½ÃÀå ºÐ¼® : °¢Á¾ ºÎ¹®º°

  • ºÐ·ù ³»¿ª
  • ½ÃÀå ºÐ¼® : Å×½ºÆ® À¯Çüº°
  • ÇǺΠ¹ÝÀÀ Å×½ºÆ®(SPT)
  • ÆÐÄ¡ Å×½ºÆ®
  • Çdz» Å×½ºÆ®
  • ½ÃÀå ºÐ¼® : ¿ëµµº°
  • ¾Ë·¹¸£±â ºñ¿°
  • ¾Ë·¹¸£±â¼º õ½Ä
  • ¾àÁ¦ ¾Ë·¹¸£±â
  • ¾Ë·¹¸£±â¼º °á¸·¿°
  • ¾Æ³ªÇʶô½Ã½º
  • ±âŸ
  • ½ÃÀå ºÐ¼® : ÃÖÁ¾»ç¿ëÀÚº°
  • º´¿ø¡¤Áø·á¼Ò
  • Áø´Ü ¼¾ÅÍ
  • ±âŸ
  • ½ÃÀå ºÐ¼® : Áö¿ªº°
  • À¯·´
  • ºÏ¹Ì
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ±âŸ Áö¿ª

Á¦6Àå °æÀï Á¤º¸

  • ½ÃÀå ºÐ¼®
  • ÁÖ¿ä ±â¾÷
  • Àü·« ºÐ¼®

Á¦7Àå ÇǺΠ¾Ë·¹¸£±â °Ë»çÀÇ Áö¼Ó°¡´É¼º : ESG °üÁ¡

  • ESG : ¼Ò°³
  • ÇǺΠ¾Ë·¹¸£±â °Ë»ç ¾÷°èÀÇ Áö¼Ó°¡´É¼º : ESG °üÁ¡
  • ÁÖ¿ä ESG ¹®Á¦
  • ÇǺΠ¾Ë·¹¸£±â °Ë»ç ¾÷°è : ESG ÆÛÆ÷¸Õ½º ºÐ¼®
  • BCC¿¡ ÀÇÇÑ °á·Ð

Á¦8Àå ºÎ·Ï

  • Á¶»ç ¹æ¹ý
  • Á¤º¸ Ãâó
  • µÎ¹®ÀÚ¾î
  • ±â¾÷ °³¿ä
  • ALK-ABELLO A/S
  • ALL CURE PHARMA
  • ALLERGY THERAPEUTICS
  • CHEMOTECHNIQUE MB DIAGNOSTICS AB
  • DERMAPHARM HOLDING SE
  • HAL ALLERGY B.V.
  • JUBILANT PHARMOVA LTD.
  • LINCOLN DIAGNOSTICS INC.
  • SMARTPRACTICE.COM
  • STALLERGENES GREER
ksm 24.05.07

The global market for skin allergy testing is expected to grow from $560 million in 2023 to $771.5 million by the end of 2028, at a compound annual growth rate (CAGR) of 6.6% from 2023 to 2028.

The global market for skin prick test is expected to grow from $489.3 million in 2023 to $678.6 million by 2028, at a CAGR of 6.8% from 2023 to 2028.

The global market for patch test is expected to grow from $40.1 million in 2023 to $54 million by 2028, at a CAGR of 6.1% from 2023 to 2028.

Report Scope

This report provides detailed information about the global skin allergy testing market. It includes market projections for 2028 and a ranking of key market players. It also analyzes the size of the skin allergy testing market based on test types, applications and end users. For this analysis, the skin allergy testing market is broken down by test type into the following segments: prick test, patch test, and intradermal test. It should be noted that this study excludes in vitro allergy tests. Based on applications, the skin allergy testing market is segmented into allergic rhinitis, allergic asthma, drug allergy, allergic conjunctivitis, anaphylaxis and others. Based on end users, the market is segmented into hospitals and clinics, diagnostic centers and others.

Report Includes

  • 28 data tables and 28 additional tables
  • An overview of the global market for skin allergy testing
  • Analysis of global market trends, featuring revenue data for 2020-2022, estimated figures for 2023, and forecasts for 2028. This analysis includes projected CAGRs through 2028
  • Evaluation of the current market size and revenue growth prospects specific to skin allergy testing, along with a market share analysis by test type, application, end user and region
  • Insights into R&D related to skin allergy testing and emerging technologies, as well as government regulations and mandates, and general economic trends
  • Discussion of how to overcome challenges related to commercialization
  • A look at ESG trends
  • Analysis of companies' market shares, proprietary technologies, alliances and patents
  • Profiles of the leading players

Table of Contents

Chapter 1 Executive Summary

  • Market Outlook
  • Scope of Report
  • Market Summary

Chapter 2 Market Overview

  • Overview
  • PESTEL Analysis
  • Porter's Five Forces Analysis
  • Supply Chain Analysis

Chapter 3 Market Dynamics

  • Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
  • Challenges

Chapter 4 Emerging Technologies and Developments

  • Emerging Technologies
  • Automated Skin Prick Test Devices
  • Digitalization
  • Artificial Intelligence
  • Clinical Trials Analysis
  • Clinical Trials Analysis, by Type of Study
  • Clinical Trials Analysis, by Status
  • Clinical Trials Analysis, by Phase
  • Selected Clinical Trials
  • Patent Analysis
  • Patents, by Year
  • Patents, by Top Applicant
  • Patents, by Top Owner
  • Patents, by Jurisdiction

Chapter 5 Market Segmentation Analysis

  • Segmentation Breakdown
  • Market Analysis, by Test Type
  • Skin Prick Test (SPT)
  • Patch Test
  • Intradermal Test
  • Market Analysis, by Application
  • Allergy Rhinitis
  • Allergic Asthma
  • Drug Allergy
  • Allergic Conjunctivitis
  • Anaphylaxis
  • Others
  • Market Analysis, by End User
  • Hospitals and Clinics
  • Diagnostic Centers
  • Other End Users
  • Geographic Breakdown
  • Market Analysis, by Region
  • Europe
  • North America
  • Asia-Pacific
  • Rest of the World

Chapter 6 Competitive Intelligence

  • Market Analysis
  • Top Players
  • Strategic Analysis

Chapter 7 Sustainability in Skin Allergy Testing: An ESG Perspective

  • Introduction to ESG
  • Sustainability in Skin Allergy Testing Industry: An ESG Perspective
  • Key ESG Issues
  • Skin Allergy Testing Industry: ESG Performance Analysis
  • Concluding Remarks from BCC

Chapter 8 Appendix

  • Methodology
  • Sources
  • Acronyms
  • Company Profiles
  • ALK-ABELLO A/S
  • ALL CURE PHARMA
  • ALLERGY THERAPEUTICS
  • CHEMOTECHNIQUE MB DIAGNOSTICS AB
  • DERMAPHARM HOLDING SE
  • HAL ALLERGY B.V.
  • JUBILANT PHARMOVA LTD.
  • LINCOLN DIAGNOSTICS INC.
  • SMARTPRACTICE.COM
  • STALLERGENES GREER
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦